Robin Steele

Board Member at OcuTerra Therapeutics

Robin Steele has extensive experience in conventional debt and equity financings, as well as other financing related transactions such as mergers and acquisitions, product in/out-licenses and divestitures, collaborative agreements, and spin-offs. Robin previously served as Senior Vice President, General Counsel and Secretary of InterMune, Inc., a publicly traded biopharmaceutical company, until 2014. Prior to her tenure with InterMune, Robin served as Vice President of Legal Affairs for North America for Elan Pharmaceuticals, a publicly traded pharmaceutical company. Robin received an LL.M in Taxation from New York University School of Law and a J.D. from the University of California, Hastings College of the Law.

Links

Timeline

  • Board Member

    Current role